• We are dedicated to
    the future of clinical development
    and to every life it saves.

    Learn more about why we do what we do, and what we can do for you. Click to read our story.

Social Media

See the latest interactions from our social media

Google+

Meet PRA's team at Outsourcing in #ClinicalTrials (OCT) East Coast 2016, May 25-26 2016, King of Prussia...


View Post

Featured News

Read the latest updates from our PR department

PRA Health Sciences Named International Clinical Research Company of the Year

RALEIGH, N.C., May 17, 2016 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc., (PRA) (NASDAQ:PRAH) is pleased to announce that for the third consecutive year it was recognized as the Clinical Research Company [...]

PRA Health Sciences, Inc. Announces Secondary Offering of 5,000,000 Shares of Common Stock

RALEIGH, N.C., May 02, 2016 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (the “Company”) (NASDAQ:PRAH) today announced that certain of its stockholders (the “Selling Stockholders”), intend to [...]

PRA Health Sciences, Inc. Reports First Quarter 2016 Results and Updates 2016 Guidance

$372.3 million of service revenue in the first quarter; 13.0% constant currency growth compared to the first quarter of 2015   First quarter GAAP Net Loss of $16.0 million or $0.27 per diluted share, [...]

Read More >

Media Resources

Explore the latest resources uploaded to our media library

Sign Up for PRA's Industry Watch

Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter

CASE STUDY: PRA Feasibility Leads To Unique Enrollment Strategy

PRA recently performed a feasibility study to identify investigators who see patients with a rare neuromuscular autoimmune disease and who have the capability to perform a Phase II clinical trial.

FACT SHEET: CNS

PRA Health Sciences provides our clients with innovative solutions for CNS (neurology, psychiatry, and pain) drug development. Our work spans from early phase development to NDA and MAA submissions...

CASE STUDY: PRA Teamwork Demonstrates Vision

A large pharmaceutical client selected PRA to conduct 2 Phase III epilepsy studies in India, Eastern and Western Europe, and Australia. PRA’s project teams surpassed recruitment goals and achieved timely site activations despite administrative delays and tough competition for volunteers.

Events

Find out what's happening next on PRA's event schedule

INTERNATIONAL CONFERENCE ON OPIOIDS (ICOO) 2016
June 5 - June 7

Opioids are effective tools when used properly in the management of pain. They are cost effective and allow increased numbers of patients to return to active productive lives in society. Yet, while opioids have been with us for over 4000 years, the landscape of opioid therapies is rapidly evolving. Federal and state regulations are swiftly […]

DIA 2016
June 26 - June 30

DIA 2016 is the largest global interdisciplinary event that brings together key thought leaders and innovators from industry, academia, regulatory and government agencies, health, patient, and philanthropic organizations from around the globe – and across all disciplines involved in the discovery, development, and life cycle management of health care products. The goal of the DIA […]

LAND O’LAKES CONFERENCE
July 11 - July 14

The Land o’Lakes conference seeks to provide an educational forum to discuss issues and applications associated with the analysis of overall approaches associated with Biomarker validation, stability and the associated regulatory concerns that come from this growing area of research. Speakers will present information from new and innovative areas of bioanalysis of biologic therapeutics, small […]

Read More >